Ensysce Biosciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Sep 2017 | $380.0K | $400.0K | — |
| Dec 2017 | $11.8M | — | — |
| Dec 2017 | $12.8M | $202.4M | — |
| Mar 2018 | $12.5M | $202.9M | — |
| Jun 2018 | $12.7M | $203.2M | — |
| Sep 2018 | $14.7M | $204.0M | — |
| Dec 2018 | $13.2M | $204.8M | — |
| Mar 2019 | $12.8M | $205.6M | — |
| Jun 2019 | $13.2M | $206.4M | — |
| Sep 2019 | $13.7M | $207.2M | — |
| Dec 2019 | $17.5M | $196.5M | — |
| Mar 2020 | $57.1M | $61.6M | — |
| Jun 2020 | $16.1M | $13.4M | — |
| Sep 2020 | $11.8M | $13.3M | — |
| Dec 2020 | $7.0M | $351.8K | $194.2K |
| Mar 2021 | $11.1M | $13.0M | — |
| Jun 2021 | $4.0M | $9.2M | $8.0M |
| Sep 2021 | $10.1M | $9.7M | $6.8M |
| Dec 2021 | $24.6M | $16.4M | $12.3M |
| Mar 2022 | $11.3M | $12.4M | $8.4M |
| Jun 2022 | $8.7M | $7.9M | $3.7M |
| Sep 2022 | $14.7M | $8.3M | $4.5M |
| Dec 2022 | $9.9M | $5.9M | $3.1M |
| Mar 2023 | $4.1M | $3.9M | $1.4M |
| Jun 2023 | $2.6M | $6.4M | $3.8M |
| Sep 2023 | $2.1M | $3.2M | $1.5M |
| Dec 2023 | $3.4M | $2.7M | $1.1M |
| Mar 2024 | $1.7M | $5.1M | $3.4M |
| Jun 2024 | $1.3M | $2.8M | $1.0M |
| Sep 2024 | $2.8M | $9.4M | $4.2M |
| Dec 2024 | $2.2M | $5.6M | $3.5M |
| Mar 2025 | $1.9M | $4.6M | $3.1M |
| Jun 2025 | $2.5M | $5.6M | $2.2M |
| Sep 2025 | $2.3M | $3.2M | $1.7M |
| Dec 2025 | $4.6M | $7.5M | $4.3M |
| Mar 2026 | $2.8M | $2.2M | $745.5K |
| Jun 2026 | $4.1M | $3.0M | $676.7K |